OTCMKTS:BINDQ

(BINDQ) (BINDQ) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.15
$0.15
50-Day Range
N/A
52-Week Range
$0.11
$5.24
Volume
N/A
Average Volume
660,601 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About (BINDQ)

DNIB Unwind, Inc., formerly BIND Therapeutics, Inc. is a shell company. The Company was engaged in developing targeted therapeutics, primarily for the treatment of cancer. As of August 1, 2016, the Company sold all of its assets. The Company's subsidiaries include BIND (RUS) LLC and DNIB Subsidiary Corporation.

BINDQ Stock News Headlines

😱 This phenomenon is smashing regular market gains
Thanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.
DNIB Unwind Inc (BINDQ)
See More Headlines
Receive BINDQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (BINDQ) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:BINDQ
Previous Symbol
NASDAQ:BIND
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (OTCMKTS:BINDQ) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners